← All companies
DANAHER CORP /DE/
DHR - CIK 0000313616
Market cap$130.16 B
Rank#114
SEC filings1,026
DANAHER CORP /DE/ trades as DHR and has a market capitalization of $130.16 B, making it the #114 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $24.57B, up 2.9% from the prior year and net income of $3.61B. This page tracks DANAHER CORP /DE/ through 1,026 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$24.57BFY 2025
Net income (latest FY)$3.61BFY 2025
Operating cash flow (latest FY)$6.42BFY 2025
Total assets (latest FY)$83.46BFY 2025
Gross margin59.1%latest FY
Net margin14.7%latest FY
Financial performance
Over the last 9 fiscal years DANAHER CORP /DE/'s revenue grew from $16.88B to $24.57B, a compound annual growth rate of 4.3%. Net profit margin compressed from 15.1% to 14.7% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $130.16 B
- Share price (derived)market cap / shares outstanding
- $183.89
- P/E ratio (trailing FY)
- 36.0
- EPS (diluted)FY 2025
- $5.05
- Shares outstandingas of 2026-04-16
- 0.71B
- Total equityas of 2026-03-27
- $52.95B
- Return on equity
- 6.8%
- Long-term debtas of 2026-03-27
- $18.48B
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
Recent press releases
- 2026 05 05 Danaher Announces Quarterly Dividend2026-05-05
/Title (��Danaher Announces Quarterly Dividend - May 5, 2026)
- Danaher Announces Quarterly Dividend2026-05-05
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve many of their most complex scientific and clinical challenges—helping move innovations from discovery to delivery faster for patients who depend on them.
- 2026 04 22 Danaher Announces Pricing Of Euro Denominated Senior Notes Offering2026-04-22
/Title (��Danaher Announces Pricing of Euro-Denominated Senior Notes Offering - Apr 22, 2026)
- Danaher Announces Pricing of Euro-Denominated Senior Notes Offering2026-04-22
€500,000,000 principal amount of floating rate senior notes due 2028 at an offering price of 100.000% of the principal amount;
- 2026 04 21 Danaher Reports First Quarter 2026 Results2026-04-21
/Title (��Danaher Reports First Quarter 2026 Results - Apr 21, 2026)
Similar companies
The largest companies sharing DANAHER CORP /DE/'s SEC industry classification (industrial instruments for measurement, display, and control).
Frequently asked questions
What is DANAHER CORP /DE/'s market cap?
DANAHER CORP /DE/ (DHR) has a market capitalization of $130.16 B as of 2026-06-10, ranking #114 among US-listed companies.
How much revenue does DANAHER CORP /DE/ make?
DANAHER CORP /DE/ reported revenue of $24.57B for fiscal year 2025, an increase of 2.9% year over year.
Is DANAHER CORP /DE/ profitable?
Yes. DANAHER CORP /DE/ reported net income of $3.61B in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.